Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06442384 · ClinicalTrials.gov registry record · NA
Remote Trial - Tobacco Product Standard (VLNC)
A NA study, sponsored by Masonic Cancer Center, University of Minnesota.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT06442384 is a NA study that was terminated before completion, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 11 participants.
The verdict
NCT06442384, a NA study, was terminated before completion, sponsored by Masonic Cancer Center, University of Minnesota.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The goal of this pilot project is to explore the feasibility of a real-world marketplace study design examining the effects of a reduced nicotine product standard for cigarettes on smoking in the context of a flavor restriction vs. no restriction on e-cigarettes in smokers switched to very low nicotine content cigarettes.
Interventions
- OTHER Tobacco and non-tobacco e-cigarettes
- OTHER Tobacco only e-cigarettes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-09-11 |
| Est. Completion | 2025-04-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06442384
The ClinicalTrials.gov registry entry for NCT06442384 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tobacco and non-tobacco e-cigarettes is the first listed.
NCT06442384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06442384 about?
NCT06442384 is a clinical study titled "Remote Trial - Tobacco Product Standard (VLNC)". The goal of this pilot project is to explore the feasibility of a real-world marketplace study design examining the effects of a reduced nicotine product standard for cigarettes on smoking in the context of a flavor restriction vs. no restriction on e-cigarettes in smokers switched to very low nicot...
What is the current status of trial NCT06442384?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2024-09-11. Estimated completion is 2025-04-07.
What interventions are being tested in trial NCT06442384?
The interventions under investigation include: Tobacco and non-tobacco e-cigarettes (OTHER), Tobacco only e-cigarettes (OTHER).
Who is sponsoring clinical trial NCT06442384?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.